Enrico Lupia Selected Research

Leukocytosis (Pleocytosis)

1/2018

Derivation and Validation of a Biomarker-Based Clinical Algorithm to Rule Out Sepsis From Noninfectious Systemic Inflammatory Response Syndrome at Emergency Department Admission: A Multicenter Prospective Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enrico Lupia Research Topics

Disease

13	Sepsis (Septicemia) 11/2022 - 06/2013
6	Acute Aortic Syndrome 01/2024 - 02/2016
5	COVID-19 10/2023 - 01/2021
4	Septic Shock (Toxic Shock Syndrome) 06/2021 - 09/2010
4	Aortic Dissection 10/2020 - 02/2013
3	Infections 02/2022 - 10/2014
3	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2018 - 07/2013
3	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2017 - 04/2003
3	Pancreatitis 01/2017 - 12/2004
3	Reperfusion Injury 01/2016 - 08/2003
2	Ischemia 11/2022 - 01/2016
2	Thrombocytopenia (Thrombopenia) 01/2022 - 10/2014
2	Acute Coronary Syndrome 06/2021 - 12/2006
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2021 - 04/2003
2	Neoplasms (Cancer) 02/2021 - 10/2007
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2020 - 07/2019
2	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2017 - 07/2005
2	Inflammation (Inflammations) 02/2012 - 08/2003
2	Type 2 Diabetes Mellitus (MODY) 06/2009 - 04/2003
2	Diabetic Nephropathies (Diabetic Nephropathy) 06/2009 - 04/2003
2	Proteinuria 06/2009 - 07/2005
1	Healthcare-Associated Pneumonia 04/2024
1	Pneumonia (Pneumonitis) 04/2024
1	Necrosis 12/2022
1	Acute Lung Injury 12/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2022
1	Critical Illness (Critically Ill) 11/2022
1	Thromboinflammation 11/2022
1	Thrombosis (Thrombus) 03/2022
1	Hepatocellular Carcinoma (Hepatoma) 02/2021
1	Fibrosis (Cirrhosis) 02/2021
1	Hypoxia (Hypoxemia) 02/2021
1	Liver Neoplasms (Liver Cancer) 02/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2021
1	Dementia (Dementias) 01/2021
1	Heart Failure 01/2020
1	Respiratory Acidosis 07/2019
1	Respiratory Insufficiency (Respiratory Failure) 07/2019
1	Hyperthermia 01/2018
1	Leukocytosis (Pleocytosis) 01/2018
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2017
1	Abdominal Pain (Pain, Abdominal) 01/2017
1	Cardiotoxicity 01/2016
1	Primary Graft Dysfunction 01/2016
1	Endotoxemia 01/2016
1	Edema (Dropsy) 01/2016

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 01/2024 - 06/2013
9	Thrombopoietin (c-mpl Ligand)IBA 11/2022 - 12/2006
6	fibrin fragment D (D-dimer)IBA 03/2023 - 07/2014
5	Proteins (Proteins, Gene)FDA Link 02/2021 - 07/2005
5	ProcalcitoninIBA 01/2018 - 06/2013
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2021 - 10/2014
3	4,5,6,7- tetrahydroisoxazolo(4,5- c)pyridin- 3- ol (THPO)IBA 11/2022 - 02/2021
3	nephrinIBA 02/2007 - 04/2003
2	Interleukin-6 (Interleukin 6)IBA 11/2022 - 01/2021
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 11/2022 - 01/2021
2	LipidsIBA 03/2022 - 09/2003
2	AnticoagulantsIBA 01/2022 - 02/2012
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 02/2012
2	Messenger RNA (mRNA)IBA 02/2021 - 01/2016
2	Small Interfering RNA (siRNA)IBA 02/2021 - 01/2016
2	CytokinesIBA 01/2021 - 01/2016
2	Group II Phospholipases A2IBA 01/2018 - 06/2013
2	C-Reactive ProteinIBA 01/2018 - 10/2014
2	SteroidsIBA 01/2017 - 07/2005
2	Natriuretic PeptidesIBA 07/2015 - 06/2013
2	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2014 - 12/2004
2	AlbuminsIBA 06/2009 - 04/2003
2	matrigelIBA 10/2007 - 09/2003
2	Platelet Activating FactorIBA 10/2007 - 08/2003
1	Cephalosporins (Cephalosporin Antibiotics)IBA 04/2024
1	ceftobiproleIBA 04/2024
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 12/2022
1	Interleukin-10 (Interleukin 10)IBA 12/2022
1	Interleukin-8 (Interleukin 8)IBA 12/2022
1	InterleukinsIBA 12/2022
1	Hemostatics (Antihemorrhagics)IBA 11/2022
1	tocilizumab (atlizumab)FDA Link 11/2022
1	Proprotein Convertase 9IBA 03/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 03/2022
1	NADP (NADPH)IBA 03/2022
1	Hemoglobins (Hemoglobin)IBA 02/2022
1	proadrenomedullinIBA 02/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	growth arrest-specific protein 6IBA 01/2022
1	LigandsIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2021
1	AntigensIBA 01/2021
1	brassIBA 01/2021
1	Carbon DioxideIBA 07/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016

Therapy/Procedure

3	Therapeutics 12/2020 - 01/2018
2	Noninvasive Ventilation 12/2020 - 07/2019
1	Patient Transfer (Patient Dumping) 10/2023
1	Plasma Exchange 01/2017
1	Punctures 01/2016
1	Ligation 01/2016
1	Lung Transplantation 01/2016
1	Aftercare (After-Treatment) 01/2016